Abstract:Ethnopharmacological relevance: This study addresses the rapid discovery of the active compounds (the original constituents and/or metabolites) of a traditional Chinese drug, Smilacis Glabrae Rhizoma (SGR). Aim of the study: The aim of this study was to develop a new method to find out the active compounds of traditional drugs in vivo. Materials and methods: A method was established to discover and identify the potential active compounds in drug-containing plasma from rats that were orally administered SGR extract, utilizing the relationship between the individual differences in blood drug concentrations in the rats and the resulting differences in pharmacological effect, and the method was denoted as the RID-PE method. For this method, we used high-performance liquid chromatography with a diode array detector combined with electrospray ionization ion trap time-of-flight multistage mass spectrometry (LC-MSn) to identify the compounds (the original constituents and metabolites) and to determine the peak areas of the compounds in drug-containing plasma following SGR treatment. The anti-inflammatory effect of SGR was evaluated using a carrageenan-induced inflammatory rat model. According to the percent inhibition of paw edema in each model rat (14 rats total) orally administered SGR extract, the plasma samples from the rats were sorted and divided into 7 groups. Each group consisted of two plasma samples, and their percent inhibition of paw edema were similar to each other. We performed an LC-MSn analysis on 3 plasma groups, which showed large differences in the inhibition rates, with percent inhibitions of 92.7%, 72.4% and 38.4%. The correlation coefficients (r) between the peak area of each compound and the pharmacological effect (inhibition ratio) of SGR in the three groups were analyzed using SPSS software. When the correlation coefficients of the compounds are greater than 0.8 (0.8 < r <= 1), these compounds are strongly and positively correlated with anti-inflammatory activity, making them potential anti-inflammatory active compounds. Results: Fifty-eight potential anti-inflammatory compounds (0.8 < r <= 1) from SGR were discovered in model rat plasma using the RID-PE method, 47 of which were considered to be new potentially anti-inflammatory compounds. Among these compounds, four original constituents and 5 isomers of potential anti-inflammatory metabolites were validated to have significant anti-inflammatory effects, and they included astilbin, syringic acid, catechin, coumalic acid, resveratrol-3'-O-glucuronide (RG, isomer of M2 or M3), 3'-O-methyl-(+)-epicatechin-4'-O-glucuronide (CA-1, isomer of M16), 4'-O-methyl-(+)-epicatechin-3'-O-glucuronide (CA-2, isomer of M16), 4'-O-methyl-(+)-epicatechin-7-O-glucuronide (CA-3, isomer of M16) and 3'-O-methyl-(+)-epicatechin-7-O-glucuronide (CA-4, isomer of M16). In addition, four isomers (CA-1-CA-4) were reported to have anti-inflammatory effects for the first time, and CA-3 was a new compound. Conclusions: The RID-PE method can be used to discover and identify the active constituents and metabolites of SGR systematically and in vivo. Furthermore, these findings enhance our understanding of the metabolism and effective forms of SGR.

Exploring in Vitro, in Vivo Metabolism of Mogroside V and Distribution of Its Metabolites in Rats by Hplc-Esi-It-Tof-Msn

Identification and Analysis of Harpagide Metabolites in Rats in vivo

Identification of Constituents in Gui-Zhi-Jia-Ge-Gen-Tang by LC-IT-MS Combined with LC-Q-TOF-MS and Elucidation of Their Metabolic Networks in Rat Plasma after Oral Administration.

Investigation of the in Vivo Metabolism of Sibirioside A and Angoroside C in Rats by HPLC-ESI-IT-TOF-MSn.

Metabolites of Siamenoside I and Their Distributions in Rats

Simultaneous Determination Of Notoginsenoside R1, Ginsenoside Rg(1), Re, Rb-1 And Icariin In Rat Plasma By Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry

Characterization of metabolites of sagittatoside B in rats using UPLC-QTOF-MS spectrometry

The Metabolism of a Natural Product Mogroside V, in Healthy and Type 2 Diabetic Rats.

Discovery of the Active Compounds of Smilacis Glabrae Rhizoma by Utilizing the Relationship Between the Individual Differences in Blood Drug Concentration and the Pharmacological Effect in Rats.

Metabolism of Two Mogroside Isomers, Mogroside III and Mogroside IIIE, in Normal and Drug-Metabolizing Enzyme-Induced Rats.

Methodology of enzymic hydrolysis of fifty percent mogroside V

Exploring the In Vivo Existence Forms (23 Original Constituents and 147 Metabolites) of Astragali Radix Total Flavonoids and Their Distributions in Rats Using HPLC-DAD-ESI-IT-TOF-MSn

Metabolites of Medicarpin and Their Distributions in Rats

Identification and mechanism prediction of mulberroside A metabolites in vivo and in vitro of rats using an integrated strategy of UHPLC-Q-Exactive Plus Orbitrap MS and network pharmacology

An integrated strategy for profiling the chemical components of Scutellariae Radix and their exogenous substances in rats by ultra-high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry

Identification of Metabolites of Geniposide in Rat Urine Using Ultra-Performance Liquid Chromatography Combined with Electrospray Ionization Quadrupole Time-of-flight Tandem Mass Spectrometry.

Exploration of the profiles of steroidal saponins from Rhizoma Paridis and their metabolites in rats by UPLC‐Q‐TOF‐MS/MS

Simultaneous Determination of Luteoloside, Apigetrin, And Hesperidin In Rat Plasma By UHPLC-MS/MS: Application to A Comparative Pharmacokinetic Investigation After Oral Administration Of Schizonepeta Tenuifolia Aqueous Extract With And Without Its Volatile Oil

In Vitro/In Vivo Metabolism of Ginsenoside Rg5 in Rat Using Ultra-Performance Liquid Chromatography/Quadrupole-Time-of-Flight Mass Spectrometry

An integrated strategy to delineate the chemical and dynamic metabolic profile of Huachansu tablets in rat plasma based on UPLC-ESI-QTOF/MS E

Identification of in vitro-in vivo components of Caoguo using accelerated solvent extraction combined with gas chromatography-mass spectrometry integrated with network pharmacology on indigestion